Yusuf Al-Hiari Selected Research

Yusuf Al-Hiari Research Topics

Disease

8	Hyperlipidemias (Hyperlipidemia) 07/2023 - 09/2009
6	Inflammation (Inflammations) 12/2022 - 01/2019
6	Neoplasms (Cancer) 07/2022 - 01/2017
4	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 01/2019
4	Body Weight (Weight, Body) 09/2011 - 09/2009
2	Leukemia 01/2020 - 01/2017
2	Obesity 01/2019 - 09/2013
1	Breast Neoplasms (Breast Cancer) 12/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022
1	Prostatic Neoplasms (Prostate Cancer) 07/2022
1	Carcinoma (Carcinomatosis) 07/2022
1	Diabetes Complications 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Insulin Resistance 09/2013

Drug/Important Bio-Agent (IBA)

5	FluoroquinolonesIBA 07/2022 - 01/2019
4	tyloxapol FDA Link 07/2023 - 09/2009
4	Antineoplastic Agents (Antineoplastics)IBA 12/2022 - 01/2019
4	Cisplatin (Platino)FDA LinkGeneric 05/2022 - 01/2019
4	Triglycerides (Triacylglycerol)IBA 09/2011 - 09/2009
3	Indomethacin (Indometacin)FDA LinkGeneric 12/2022 - 01/2020
3	LipopolysaccharidesIBA 05/2022 - 01/2020
3	LipidsIBA 01/2018 - 09/2009
3	BezafibrateIBA 07/2017 - 05/2010
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2022 - 01/2020
2	lissamine rhodamine B (sulforhodamine B)IBA 05/2022 - 01/2022
2	Chelating AgentsIBA 01/2022 - 01/2020
2	Proton Pump InhibitorsIBA 01/2020 - 01/2020
2	Esomeprazole (Nexium)FDA Link 01/2020 - 01/2020
2	Lansoprazole (Prevacid)FDA LinkGeneric 01/2020 - 01/2020
2	Omeprazole (Prilosec)FDA LinkGeneric 01/2020 - 01/2020
2	Hypolipidemic Agents (Antihyperlipidemics)IBA 10/2017 - 09/2009
1	Rosuvastatin Calcium (Crestor)FDA Link 12/2022
1	cerivastatin (Kazak)FDA Link 12/2022
1	Pravastatin (Pravachol)FDA LinkGeneric 12/2022
1	AcidsIBA 01/2022
1	DiaminesIBA 01/2022
1	Atorvastatin (Lipitor)FDA Link 01/2020
1	Clopidogrel (Plavix)FDA Link 01/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020
1	Pioglitazone (Actos)FDA Link 01/2020
1	ThiazolidinedionesIBA 01/2020
1	Piroxicam (Feldene)FDA LinkGeneric 01/2020
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Gemifloxacin (Factive)FDA Link 01/2020
1	ThienopyridinesIBA 01/2020
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2019
1	EnzymesIBA 01/2019
1	Lipase (Acid Lipase)FDA Link 01/2019
1	Advanced Glycation End ProductsIBA 01/2019
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2019
1	IncretinsIBA 01/2019
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2019
1	AntioxidantsIBA 10/2017
1	CholesterolIBA 07/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2017
1	Lipoproteins (Lipoprotein)IBA 07/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	phosphatidylinositol mannosideIBA 01/2017
1	N- (benzoylphenyl)- 5- fluoro- 1H- indole- 2- carboxamideIBA 08/2010
1	indoleIBA 09/2009

Therapy/Procedure

4	Intraperitoneal Injections 07/2023 - 09/2009
3	Therapeutics 01/2020 - 09/2013
1	Drug Therapy (Chemotherapy) 01/2020